Results 191 to 200 of about 29,190 (239)

Approach to the patient: therapeutic mitigation of lacrimal manifestations in thyroid eye disease. [PDF]

J Clin Endocrinol Metab
Reinhardt C, Fotovat N, Siddiqui O, Ong J, Aakalu VK, Smith TJ.   +5 more
europepmc   +1 more source

Alternative Management for Refractory Keloids. [PDF]

Dermatol Pract Concept
Arboleda AJ, Alba MCS, Linthon SA, Polania BFS.   +3 more
europepmc   +1 more source

Comparative outcomes of posterior sub-Tenon triamcinolone for pseudophakic cystoid macular edema in diabetic and non-diabetic patients: a retrospective study. [PDF]

BMC Ophthalmol
Demir K, Çelik E.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

TRIAMCINOLONE MYOPATHY

Lancet, The, 1959
exaly   +3 more sources

Triamcinolone

Reactions Weekly, 2022
openaire   +2 more sources

TRIAMCINOLONE

The Lancet, 1958
F D, HART, J R, GOLDING, D, BURLEY
openaire   +2 more sources

Triamcinolone

Reactions Weekly, 2011
  +4 more sources

Intravitreal Triamcinolone

Ophthalmology, 2009
Mark C, Gillies, Judy M, Simpson, Meidong, Zhu, Grace, Hunt, Haipha, Ali, Christine, Gaston   +5 more
openaire   +2 more sources

Triamcinolone

Reactions Weekly
  +6 more sources